Innovations :Curing the Incurable. Disease Burden: Key disease conditions DiseasePrevalence :2005Prevalence (E): 2015 Cardiovascular36 Million62 Million.

Slides:



Advertisements
Similar presentations
Health Doing Business with the World - The new role of corporate leadership in global development Geneva, September 2007 World Business Council for Sustainable.
Advertisements

Select China as an Alternative Destination
The TB Alliance-Bayer Moxifloxacin Deal
UBS – 2006 Global Real Estate Conference Delivering Value Across Europe Robert Watson CEO.
OECD-OCDE Working Party on Employment, Paris March 2007 Pascal Marianna ELS/Employment Analysis & Policies Division Labour markets in BRICs and OECD.
UNDP RBA MDG-Based National Planning Workshop
Closing the MGD Gap Through Health Literacy Working With Civil Society and Communities Dr Bernhard Schwartländer ECOSOC Annual Ministerial Review Regional.
THE COMMONWEALTH FUND A iming Higher A State Scorecard on Health System Performance Cathy Schoen Senior Vice President The Commonwealth Fund Alliance for.
CONSTRUCTION FINANCE: LENDERS PERSPECTIVE Lower and Middle Income Segment.
PROCURING AND DISTRIBUTING ARVs AND OTHER A.R.T COMMODITIES IN MALAWI Technical Briefing for Consultants in Procurement and Supply Management for HIV,
No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.
Malaria Figures 3.3 billion people at risk of malaria in billion at high risk (>1 case/1000 population) mainly in the WHO African (49%) and South.
FCX Performance, Inc.. The Power of One 2 World class flow control solutions built on over 100 years of experience FCX does not run businesses; we provide.
Amanullah Saif Cost Accountant, Drug Control Administration Government of Pakistan Relationship between Tariffs, Prices and Consumption of Interferon.
CHEMOPREVENTION FOR LIVER CANCER: MARKETING AND ETHICS
June THE GROWTH STAFF PRODUCT At present Verona Building proposes in polish market:  Medium level flats  Prestigious flats in buildings with.
Stroke Management in Developing Countries Junaid A. Razzak MD PhD FACEP Chief, Section of Emergency Medicine Aga Khan University Karachi, Pakistan.
Monitoring and measuring UHC. 2 Policy and planning Monitoring and Measuring UHC Key Messages Equity is fundamental to UHC – all people get services they.
Pharmaceuticals and Global Health Inequalities and Innovation in the 21 st Century.
Nurse Led Clinics Opportunity for nurses to make a difference Wilma Scholte op Reimer, RN, PhD Amsterdam School of Health Professions Academic Medical.
HOW THE NON-STATE SECTOR ENGAGE TO STEWARDSHIP OF MIXED SYSTEM IN IN VIETNAM Health Strategy and Policy Institute - Vietnam.
Christopher Tooley Chief Executive Officer Lycamobile
Institute for Public Health, Medical Decision Making and Health Technology Assessment 1 Results of the PanEuropean Hepatitis C Project 3 rd Paris Hepatitis.
Saving a Generation: Maternal, Newborn and Child Health (MNCH) Eastern and Southern Africa Aga Khan Health Services.
Pharma/BIOTECH industry overview
Senate Education Committee Briefing Russell Ingram, Executive Director March 23, 2011.
About Us life diagnostica is an innovative company that develops strategic business alliances with foreign companies who wish to tap into the huge Indian.
Global high-level subsidy for ACT procurement to facilitate low-cost commercial, & other, distribution (allowing effective, affordable home treatment or.
Opportunities & Challenges: Expanding Access to Hepatitis C Treatment Gregg Alton Executive Vice President, Corporate & Medical Affairs.
Supply Chains Management for Pharmacy
Edo Agustian Indonesian Drug Users Network Experiencing HCV Infection – the treatment, the reality and the possibilities for Cure.
 Broad-based health care company that discovers, develops, manufactures, and markets products and services  Abbott's main businesses: ◦ Global pharmaceuticals.
COC ADVOCACY TRACK Overview of National Oncology Issues & Key COA Initiatives for 2015 Ted Okon Orlando, Florida April 23, 2015.
H EALTH INEQUALITIES IN THE NEW EU MEMBER STATES AND CANDIDATE COUNTRIES.
CURRENT PHARMACEUTICAL MARKETING STRATEGY M.ABHINANDANA M.PHARM Q.A.
Aravind Eye Care System “restoring vision to millions”
Analysis of A utomobile Industry. Introduction  Oldest  Biggest  Most extended  Ensuring the living of millions people The Automobile Industry.
Population Overload A comparison of Benin and Switzerland.
Analysing Indian Nutraceutical Market-
A Regional Focus on Advancing Health MiHIA: Michigan Health Information Alliance, Inc. Kim Morley, MiHIA CEO Phone:
1-866-SANKARA SANKARA EYE FOUNDATION, USA Vision 20/20 By The Year 2020 Eradicate curable blindness in India by providing free quality eye care to the.
BSP Contraceptive Initiative To broaden sustainable access to quality hormonal contraceptives through a new commercial venture Reproductive Health Supplies.
EMERGING TRENDS AND EVOLVING OPPORTUNITIES IN PHARMACY Dr. Amrish Chandra M.Pharm., Ph.D. AMITY UNIVERSITY, NOIDA.
Opportunity in ‘poverty’ EMBA - BA 804 Ram Mudambi Temple University.
The HCV vaccine: cooperation in the shadow of the pyramids Antonella Folgori.
Methodist Healthcare HCAD 5390.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Issues in Health Sector Sanjib Pohit December 4, 2006.
Healthcare Need & Commercial Opportunity Emerging Markets.
An Overview of the China Healthcare Market
Owen Smith – World Bank Washington DC – February 1 st, 2011 Health care financing in Georgia.
Emerging countries Implants 2012 Lyon, 31 May 2012.
Reaching Out to Remote, Underserved Communities. 2 Current Distribution System for Medical Supplies in Rural Communities Last to receive: Resources Management.
Promoting Vision 2020: The Right to Sight to eliminate avoidable blindness through capacity building in Guyana, Haiti, Jamaica, St. Lucia and the Caribbean.
How An Open Healthcare System Can Be Implemented In the US.
AIDS Acquired Immunodeficiency Syndrome (AIDS) is a disease that is spread through blood and other bodily fluids. It attacks and destroys the immune system,
Rethinking Health Innovation from the South WORKSHOP South Africa/ Cape town December 13 – 15 /2010.
Multiple Specialty Skin | Hair | Dental Chain of Clinics “ONE STOP SOLUTION”
Supporting Irish patients and the Irish economy Value of Medicines and Vaccines Delivering value to the Irish health services and the Irish economy David.
Andy Passey September 23rd 2003 Advanced Wound Management in Europe: Market Overview and Critical Success Factors © 2003 Frost & Sullivan. All rights reserved.
Rural Marketing Presentation by Komal Parelkar (89)
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
Michael Porter’s Five Forces Model.
CHAWLA MEDICOS Present’s Branded v/s Generic medicine
Finland, a Global Testbed for Personalized Cancer Research?
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
Preconditions of chronic disease March 2018
Canada Cardiovascular Prosthetic Devices Market Outlook to 2020
Expert Speak: How Pharma Companies Can Grow Their Business?
Presentation transcript:

Innovations :Curing the Incurable

Disease Burden: Key disease conditions DiseasePrevalence :2005Prevalence (E): 2015 Cardiovascular36 Million62 Million Diabetes31 Million46 Million Blindness

Healthcare Challenge Rising inequities In healthcare Huge Population Skewed Health Infrastructure Poor affordability Increasing Disease Incidence & prevalence Lack of awareness Increasing Treatment costs

The way ahead: Innovation Innovation Process innovation Technology innovation Business Model innovation

Why Innovation Today, 21st century medical technology is often delivered with 19th century organization structures, management practices, and pricing models -Michael Porter

Process Innovation: Aravind Hospital Aravind Hospital: 2,00,000+ people treated every year 60% of operations free of cost Average cost of surgery : 25US$ Average duration of surgery: 10 minutes Infection rate : 4/10,000 operations

Process Innovation: Aravind Eye Hospital Process Innovation StandardizationReproducibilityScale

Technology Innovation: Shantha Biotech Shantha Biotech: 1 st company to produce indigenous Hepatitis B Vaccine Resulting in a 30 times reduction in price of Hepatitis B Vaccine 1 st company to launch a 4 in 1 vaccine A strong pipeline of biotech drugs Major supplier of Hepatitis-B vaccines to United States Got acquired by Merieux Alliance's subsidiary ShanH in 2006

Technology Innovation: Shantha Biotech Technology Innovation Collaborative Public Private R&D Productive International Technology collaboration State of the art Manufacturing facilities

Business Model Innovation: Mankind Pharma Mankind Pharma: A compound annual growth rate of 35% over last 4 years Ranked as 9 th largest Pharma company in India Majority of sales coming from mature brands in slow growth segments Initial success came from rural areas and smaller towns Largest sales force :5000 Medical representatives Mankind presence in every village having inhabitants

Business Model Innovation: Mankind Pharma Business Model Innovation Focus on rural areas & Tier 2 &3 towns Low fixed cost, Aggressive pricing Right product mix Strong sales force Huge distribution network Easy availability

Innovation : What will it lead to……….. New Products Lowering of Cost/ price Ensure wider availability Technology Innovation Process Innovation Business Model Innovation

Thank You

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.